TickerGuard
Buy Day today: Neutral (52) Mixed market breadth · major macro event coming up
NRIX

Nurix Therapeutics Inc

Healthcare · Biotechnology

23.70$ -1.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet NRIX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
89.6% 89.3% 75.3% 65.3% 76.4% 83.1% 92.5% 88.2%
56.4% 79.0% 30.1% 16.9% 15.5% 15.4% 16.4% 35.9%
86.0% 85.6% 70.9% 62.0% 74.2% 81.0% 91.1% 86.2%
– – 2.9% 1.3% 0.3% 0.2% 0.2% –
– – – 0.0% -0.3% – – –
9.7% 8.8% 1.7% 5.3% 4.1% – – –
75.0% 121.6% 26.8% 28.2% 27.1% 43.6% 21.3% 21.7%
72.3% 36.6% 11.2% 13.9% 17.0% 24.5% 14.3% 12.6%
6.3% 10.5% 1.9% 0.8% 1.3% 2.1% 1.2% 0.4%
2.9% 3.6% 0.9% 1.4% 1.2% 1.8% 1.7% 1.6%
-81.2% -131.0% 73.2% 71.8% 72.9% 56.4% 78.7% 78.3%
-85.4% -137.3% -26.2% -46.3% -96.3% -153.3% -110.4% -145.8%
35.5% 88.2% 4.0% 9.0% 11.7% 15.3% 10.0% 12.6%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?